AIDS: Clinical Trials

19 trials for AIDS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed. 19 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 219Completed 19
Phase 13Completed 3
Phase 31Completed 1

Follow AIDS: new trials by email Literature Review of AIDS trials Research Report on AIDS

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women
Cannabis, Placebo - HIV, AIDS
Phase 2CompletedAlbert Einstein College of Medicine252020-10-232025-10-15
Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients
single dose of L-AmB, 2 doses of L-AmB, 2 weeks of L-AmB - Histoplasmosis, AIDS
Phase 2CompletedAlessandro Pasqualotto1182020-02-142025-03-14
A Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-HIV Treatment
The subjects were randomized to the treatment group of 3TC or different doses of FNC. The background drugs were EFV and TDF. - AIDS
Phase 2CompletedHenan Genuine Biotech Co., Ltd.1722017-10-102019-09-30
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
50 mg/m2 aldoxorubicin, 100 mg/m2 aldoxorubicin, 150 mg/m2 aldoxorubicin - Kaposi's Sarcoma, HIV Positive
Phase 2CompletedImmunityBio, Inc.152014-04-032024-06-11
Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults
Ad35-GRIN, MVA.HIVconsv, pSG2.HIVconsv DNA - AIDS
Phase 1 / Phase 2CompletedUniversity of Oxford722014-03-012016-05-30
Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)
DNA vaccine, DNA vaccine prime with the addition of electroporation, rTV boost - AIDS
Phase 2CompletedNational Center for AIDS/STD Control and Prevention, China CDC1502012-08-012015-05-06
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Extended-Release Naltrexone - HIV, AIDS
Phase 1 / Phase 2CompletedYale University1512011-03-012020-03-19
Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons
GSK Biologicals HIV Vaccine 732462, Placebo - AIDS
Phase 2CompletedGlaxoSmithKline1912010-11-082018-05-21
HIV/AIDS, Severe Mental Illness and Homelessness
Skills Building - Motivational Interviewing - HIV, AIDS
Phase 2CompletedBoston Medical Center2402010-10-012016-04-01
Study Targeting Affect Regulation
Resilient Affective Processing Therapy (RAPT) - HIV, AIDS
Phase 1 / Phase 2CompletedUniversity of California, San Francisco562010-09-012014-10-27
Vitamin D Dose Finding Study
Cholecalciferol (Vit D3) - HIV Infections, AIDS
Phase 2CompletedChildren's Hospital of Philadelphia442010-01-012013-09-18
Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose
GSK Biologicals' HIV vaccine (732461), Chloroquine - AIDS
Phase 2CompletedGlaxoSmithKline282009-12-012018-08-17
Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy
dimiracetam, sugar pill - Neuropathy, AIDS
Phase 2CompletedNeurotune AG1162009-10-012010-06-02
HIV Prevention for Injecting Drug Users in Kazakhstan
Couples Based HIV/STI Risk Reduction Intervention (CHSR), Renaissance Wellness Promotion (WP) - HIV, AIDS
Phase 2CompletedColumbia University6002008-05-012014-02-27
Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)
Nevirapine based therapy, Efavirenz based therapy, Rifampicin (RMP) Ethambutol (E) Isoniazid (H) Pyrazinamid (Z) - Tuberculosis, Aids
Phase 2 / Phase 3CompletedFrench National Agency for Research on AIDS and Viral Hepatitis5702007-12-012012-02-15
Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers
HIV vaccine 732461 - AIDS, HIV Infections
Phase 2CompletedGlaxoSmithKline1802007-02-202019-10-01
Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)
Efavirenz (EFV), Lamivudine (3TC), Didanosine (ddI) - HIV Infections, AIDS
Phase 2CompletedFrench National Agency for Research on AIDS and Viral Hepatitis522006-02-012011-12-05
Relaxation Response With Acupuncture for HIV Patients
relaxation response - Human Immunodeficiency Virus, AIDS
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)1002003-07-012006-08-18
L-Carnitine to Treat Fatigue in AIDS Patients
L-carnitine, Placebo - HIV Infections, AIDS
Phase 2CompletedNational Institute of Nursing Research (NINR)442002-11-012008-09-04

Narrower conditions

Acquired Immunodeficiency Syndrome (19)  ·  HIV Infections (6)  ·  Substance-Related Disorders (2)  ·  Fatigue (1)  ·  HIV Seropositivity (1)  ·  Histoplasmosis (1)  ·  Neoplasms (1)  ·  Neuralgia (1)  ·  Opioid-Related Disorders (1)  ·  Sarcoma (1)  ·  Sarcoma, Kaposi (1)  ·  Systemic carnitine deficiency (1)  ·  Tuberculosis (1)  ·  Wounds and Injuries (1)

Broader conditions

Blood-Borne Infections (19)  ·  Communicable Diseases (19)  ·  Genital Diseases (19)  ·  Immune System Diseases (19)  ·  Immunologic Deficiency Syndromes (19)  ·  Infections (19)  ·  Lentivirus Infections (19)  ·  RNA Virus Infections (19)  ·  Retroviridae Infections (19)  ·  Sexually Transmitted Diseases (19)  ·  Sexually Transmitted Diseases, Viral (19)  ·  Slow Virus Diseases (19)  ·  Urogenital Diseases (19)  ·  Virus Diseases (19)  ·  HIV Infections (13)

Interventions

Carnitine (1)  ·  Chloroquine (1)  ·  Cholecalciferol (1)  ·  Didanosine (1)  ·  Ethambutol (1)  ·  Isoniazid (1)  ·  Lamivudine (1)  ·  Naltrexone (1)  ·  Protons (1)  ·  Pyrazinamide (1)  ·  Rifampin (1)  ·  Sugars (1)  ·  Vaccines, DNA (1)  ·  dimiracetam (1)  ·  efavirenz (1)

Sponsors

GlaxoSmithKline (3)  ·  French National Agency for Research on AIDS and Viral Hepatitis (2)  ·  Albert Einstein College of Medicine (1)  ·  Alessandro Pasqualotto (1)  ·  Boston Medical Center (1)  ·  Children's Hospital of Philadelphia (1)  ·  Columbia University (1)  ·  Henan Genuine Biotech Co., Ltd. (1)  ·  ImmunityBio, Inc. (1)  ·  National Center for AIDS/STD Control and Prevention, China CDC (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  National Institute of Nursing Research (NINR) (1)  ·  Neurotune AG (1)  ·  University of California, San Francisco (1)  ·  University of Oxford (1)

Countries

United States (9)  ·  Belgium (2)  ·  China (2)  ·  Brazil (1)  ·  Burkina Faso (1)  ·  France (1)  ·  Germany (1)  ·  Kazakhstan (1)  ·  Kenya (1)  ·  Mozambique (1)  ·  South Africa (1)  ·  Spain (1)

Top investigators

Aboubacar Nacro, MD (1)  ·  Adam Carrico, PhD (1)  ·  Anjali Sharma, MD, MS (1)  ·  Bei-Hung Chang, Sc.D (1)  ·  Daiane Dalla Lana, PhD (1)  ·  Daniel R Malan, MD (1)  ·  Frederick L Altice (1)  ·  Hao Wu, M.D. (1)  ·  Jori Berger-Greenstein, PhD (1)  ·  Maryline Bonnet, MD (1)  ·  Nabila El-Bassel (1)  ·  Nilesh Bhatt, MD (1)  ·  Philippe Msellati, MD, PhD (1)  ·  Ricardo Cruciani, MD, PhD (1)

Results publications

PMID 24391139, PMID 20516271, PMID 21208909, PMID 21300566, PMID 21857286, PMID 23059649, PMID 23433590, PMID 23719348, PMID 24663014, PMID 24674234, PMID 26560326, PMID 26625449, PMID 29373393, PMID 40342086

NIH funding

K02DA032322 (1), R01AT005531 (1), R21AG059505 (1)